Skip to main content

Advertisement

You are viewing the new article page. Let us know what you think. Return to old version

Erratum | Open | Published:

Erratum to: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

The original article was published in Annals of General Psychiatry 2008 7:16

Abstract

Correction to Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S and Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. Annals of General Psychiatry 2008, 7:16. This correction reports changes in the values listed for Ziprasidone and Aripiprazole in Table Ten.

Correction

Following the publication of our article [1], it has come to our attention that there was an error with the values listed for Ziprasidone and Aripiprazole in Table Ten. Table Ten should therefore appear as shown in this correction (Table 1).

Table 1 Mean annual number of stable days and cost per patient by pharmaceutical treatment.

References

  1. 1.

    Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S, Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. Annals of General Psychiatry. 2008, 7: 16-10.1186/1744-859X-7-16.

Download references

Author information

Correspondence to Sotiria Papanicolaou.

Additional information

The online version of the original article can be found at 10.1186/1744-859X-7-16

Rights and permissions

Reprints and Permissions

About this article